Attorney for Transvaginal Mesh Patients Asks FDA to Make Regulatory Changes
Attorney for Transvaginal Mesh Patients Asks FDA to Make Regulatory Changes In a letter dated August 22, 2011, Phoenix attorney Van O’Steen asked the Federal Food and Drug Administration (FDA) to make regulatory changes affecting the use of transvaginal surgical mesh implants for treatment of pelvic organ prolapse (POP) and Stress Urinary Incontinence (SUI). O’Steen’s law firm represents a number of women throughout the United States who have experienced serious complications following surgery to implant vaginal mesh devices. Phoenix, Arizona (PRWEB) August 22, 2011 In a letter dated Au
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
Categories
- Articles 309
- Bankruptcy 44
- Business 134
- Cases & Codes 68
- Contracts 27
- Criminal Law 122
- Employment 24
- Expert Reports 3
- Expert Witness 34
- Family Law 57
- Form Letters 15
- Immigration 3
- Intellectual Prop 32
- Internet Law 10
- Law Practice 99
- Law School 2
- Legal Research 19
- Litigation 186
- Miscellaneous 64
- PR Web 41689
- Personal Injury 608
- Press Release 43
- Probate 54
- Real Estate 68
- Tax Law 23
- Workers Comp 4